SmPC - Gabapentin Accord-UK 300mg Capsules: Change history
View Summary of Product Characteristics (SmPC - Gabapentin Accord-UK 300mg Capsules)
Last updated on this site: 25 Sep 2025
Description of update: To update SmPC sections 4.4, 4.6, 4.8 and 5.1 in line with reference product Neurontin 100 mg, 300 mg, 400 mg hard capsules. No Consequential update to the PIL.
Date of approval: 15/08/2025
SmPC sections updated: 4.4, 4.6, 4.8, 5.1 and 10
Last updated on this site: 25 Sep 2025
Description of update: To update SmPC sections 4.4, 4.6, 4.8 and 5.1 in line with reference product Neurontin 100 mg, 300 mg, 400 mg hard capsules. No Consequential update to the PIL.
Date of approval: 15/08/2025
SmPC sections updated: 4.4, 4.6, 4.8, 5.1 and 10
-
Changes: (Updated: 25 Sep 2025)
Description of update: To update SmPC sections 4.4, 4.6, 4.8 and 5.1 in line with reference product Neurontin 100 mg, 300 mg, 400 mg hard capsules. No Consequential update to the PIL.
Date of approval: 15/08/2025
SmPC sections updated: 4.4, 4.6, 4.8, 5.1 and 10
-
Changes: (Updated: 25 Jan 2024)
Description of update: To update section 4.6 of the SmPC in line with the reference product, Neurontin 100mg hard capsules, MAH Upjohn UK Limited. Consequently, the PIL is updated and additional editorial changes have been made.
SmPC Sections updated: 4.6 and 10.
-
Changes: (Updated: 07 Jun 2023)
Removed duplicate section 5.2
-
Changes: (Updated: 22 May 2023)
Variation Description: To register an update of the ATC code (gabapentin) from N03AX12 to N02BF01. Consequently, SmPC section 5.1 has been updated.
SmPC sections updated – 4.4, 4.6, 4.8, 5.1 and 10.
-
Changes: (Updated: 22 Sep 2022)
Initial upload